Condition
Nonalcoholic Steatohepatitis (NASH)
NASH is a serious form of fatty liver disease in which fat buildup sparks inflammation and liver cell damage, driven by metabolic problems like insulin resistance rather than alcohol. Silymarin from milk thistle has the most reviewed research, and six studies found liver enzymes improved, with moderate evidence. Betaine showed a similar improvement, though that research was small, involving only 30 people.
Sources: PMID 28785154; PMID 33418491
- Supplements studied
- 7
- Graded outcomes
- 7
- Trials
- 11
- People studied
- 3,423
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Liver Enzymes Small Improvement | Improves (the measure goes down) | Small effect | 6 studies | 437 people | ||
Studies that measured liver enzymes
| ||||||
| Total cholesterol | Improves (the measure goes down) | 166 people | ||||
| Triglycerides | Improves (the measure goes down) | 166 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Liver Enzymes Small Improvement | Improves (the measure goes down) | Small effect | 30 people | |||
| Liver Fibrosis | Changes; see studies | 1 study | 30 people | |||
Studies that measured liver fibrosis | ||||||
| Liver Fat | Changes; see studies | 30 people | ||||
Synbiotics
- Blood Pressure
- Liver Enzymes: changes; see studies
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Mixed effect | 319 people | |||||
| Liver Enzymes | Changes; see studies | 1 study | 957 people | |||
| Weight | Improves (the measure goes down) | 1 study | 701 people | |||
| Body Fat | Improves (the measure goes down) | 227 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 478 people | ||||
| Liver Fat | Improves (the measure goes down) | 137 people | ||||
| Liver Fibrosis | Improves (the measure goes down) | 238 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 233 people | ||||
| Total cholesterol | Improves (the measure goes down) | 877 people | ||||
| Waist circumference | Improves (the measure goes down) | 316 people | ||||
L-Carnitine
- Body Fat: improves
- Muscle Mass: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 71 people | ||
Studies that measured body fat | ||||||
| Muscle Mass | Improves (the measure goes up) | 3 studies | 71 people | |||
Studies that measured muscle mass
| ||||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 72 people | |||
Studies that measured oxidative stress biomarkers
| ||||||
| Liver Enzymes | Changes; see studies | 2 studies | 30 people | |||
Studies that measured liver enzymes | ||||||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 102 people | |||
Studies that measured tnf-alpha | ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 72 people | |||
| Weight | Improves (the measure goes down) | 1 study | 71 people | |||
| Glycemic Control | Improves (the measure goes up) | 30 people | ||||
| Transforming Growth Factor Beta | Improves (the measure goes up) | 72 people | ||||
| Waist circumference | Improves (the measure goes down) | 71 people | ||||
Whey Protein
- Anti-Oxidant Enzyme Profile: improves
- Weight: improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 59 people | |||
| Weight | Improves (the measure goes down) | 4 studies | 59 people | |||
Studies that measured weight
| ||||||
| Glycemic Control | Improves (the measure goes up) | 1 study | 59 people | |||
Studies that measured glycemic control | ||||||
| Liver Enzymes | Changes; see studies | 59 people | ||||
| Liver Fat | Improves (the measure goes down) | 59 people | ||||
Melatonin
- Adiponectin: improves
- Ghrelin: improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 16 people | |||
| Ghrelin | Improves (the measure goes up) | 1 study | 16 people | |||
| Glycemic Control | Improves (the measure goes up) | 16 people | ||||
| Insulin | Changes; see studies | 16 people | ||||
| Leptin | ||||||
| Liver Enzymes | Changes; see studies | 16 people | ||||
| Resistin | Improves (the measure goes up) | 16 people | ||||
Vitamin E
- Bilirubin
- Oxidative Stress Biomarkers: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 222 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 43 people | |||
Studies that measured oxidative stress biomarkers
| ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 244 people | |||
| Triglycerides | Improves (the measure goes down) | 2 studies | 244 people | |||
Studies that measured triglycerides | ||||||
| Cirrhosis Severity | Changes; see studies | 1 study | 239 people | |||
Studies that measured cirrhosis severity | ||||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 222 people | |||
| Liver Enzymes | Improves (the measure goes down) | 1 study | 1,008 people | |||
| Liver Fat | Improves (the measure goes down) | 1 study | 1,008 people | |||
| Weight | Improves (the measure goes down) | 1 study | 244 people | |||
| Blood glucose | Improves (the measure goes down) | 222 people | ||||
| Glycemic Control | Improves (the measure goes up) | 239 people | ||||
| Liver Fibrosis | Improves (the measure goes down) | 1,008 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 222 people | ||||
| Serum TGF-β | Improves (the measure goes up) | 22 people | ||||
Key findings
- Liver EnzymesImproves (the measure goes down)
- Blood Pressure
- Body FatImproves (the measure goes down)
The Nonalcoholic Steatohepatitis (NASH) protocol
2 primary supplements · 6 supporting supplements
- Vitamin E800 IU daily (alpha-tocopherol)
- Milk Thistle (Silymarin)420–600 mg silymarin daily
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Nonalcoholic Steatohepatitis (NASH). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The supplement graded A or B for Nonalcoholic Steatohepatitis (NASH). Each opens the products we list for that supplement.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
40 studies from PubMed
- Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients
- A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study
- Efficacy and Safety of Whey Protein Supplements on Vital Sign and Physical Performance Among Athletes: A Network Meta-Analysis.
- Changes in antioxidant status and cardiovascular risk factors of overweight young men after six weeks supplementation of whey protein isolate and resistance training
- Effect of whey protein supplementation on weight and body composition indicators: A meta-analysis of randomized clinical trials.
- Vitamin E for people with non-alcoholic fatty liver disease.
- Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial
- Megavitamin E supplementation in man
- Study on the effect of megavitamin E supplementation in man
- Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis.
- Long-term (>=2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis
- Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study
- Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
- Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults
- Dose dependent elevation of plasma tocotrienol levels and its effect on arterial compliance, plasma total antioxidant status, and lipid profile in healthy humans supplemented with tocotrienol rich vitamin E
- Effects of vitamin E on lipid peroxidation in healthy persons
- The relationship between dose of vitamin E and suppression of oxidative stress in humans
- Effect of synbiotics on the cardiovascular risk factors in patients with non-alcoholic fatty liver: a GRADE assessed systematic review and meta-analysis.
- The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials.
- Effects and tolerance of silymarin (milk thistle) in chronic hepatitis C virus infection patients: a meta-analysis of randomized controlled trials.
- An updated systematic review with meta-analysis for the clinical evidence of silymarin.
- Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non-alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta-Analysis.
- The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials
- Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
- Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis.
- Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin
- L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial
- Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials
- Data from a randomized and controlled trial of LCarnitine prescription for the treatment for Non- Alcoholic Fatty Liver Disease
- L-Carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women
- The effect of l-carnitine on fat oxidation, protein turnover, and body composition in slightly overweight subjects
- Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults
- L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial
- Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects
- Comparison of pre-workout nitric oxide stimulating dietary supplements on skeletal muscle oxygen saturation, blood nitrate/nitrite, lipid peroxidation, and upper body exercise performance in resistance trained men
- Single dose administration of L-carnitine improves antioxidant activities in healthy subjects
- Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue
- l-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function
- L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study
- Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study